. 2020 Jan 28;145(2):295–305. doi: 10.1097/PRS.0000000000006461
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Fig. 1.
Summary of study design. HARR, Restylane Refyne; HARD, Restylane Defyne.